Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats

European Journal of Pharmacology

Volumn 474, Issue 2-3, 2003, Pages 227-232

  Hefco, Vasile ^a   Yamada, Kiyofumi ^b   Hefco, Andreea ^a   Hritcu, Lucian ^a   Tiron, Adrian ^a   Olariu, Ana ^a   Nabeshima, Toshitaka ^b  

^a ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chlorisondamine; Memory; Nicotine; Scopolamine; Sulpiride

Indexed keywords

CHLORISONDAMINE; DOPAMINE 2 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; SCOPOLAMINE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; LATENT PERIOD; LONG TERM EXPOSURE; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SHORT TERM MEMORY; SINGLE DRUG DOSE; TASK PERFORMANCE;

ANIMALS; AVOIDANCE LEARNING; CHLORISONDAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MEMORY DISORDERS; MUSCARINIC ANTAGONISTS; NICOTINE; NICOTINIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SCOPOLAMINE;

EID: 0142134066     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02034-X     Document Type: Article

References (25)

1. Abood L.G., Reynolds D.T., Booth H., Bidlack J.M. Sites and mechanisms for nicotine's action in the brain. Neurosci. Biobehav. Rev. 5:1981;479-486.
2. Clarke P.B.S., Kumar R. Characterization of the locomotor stimulation action of nicotine in tolerant rats. Br. J. Pharmacol. 80:1983;587-594.
3. Decker M.W., Majchrzak M.J. Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic antagonist, on spatial memory in rats. Psychopharmacology. 107:1992;530-534.
4. Decker M.W., Majchrzak M.J., Cadman E.D., Arneric S.P. Effects of chlorisondamine on nicotinic receptor binding in whole brain and nicotine-induced changes in locomotor activity in rats. Drug Dev. Res. 31:1994;89-94.
5. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Diversity of neural nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci. 56:1995;545-570.
6. DeZazzo J., Tully T. Dissection of memory formation: from behavioral pharmacology to molecular genetics. Trends Neurosci. 18:1995;212-218.
7. Dunnet S.B., Martel F.L. Proactive interference effects on short-term memory in rats. Basic parameters and drug effects. Behav. Neurosci. 104:1990;655-665.
8. Dutar P., Bassant H.L., Senut M.C., Lamour Y. The septohippocampal pathway: structure and function of a central cholinergic system. Physiol. Rev. 75(2):1995;393-427.
9. Grady S., Marks M.J., Wonnacott S., Collins A.C. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59:1992;848-856.
10. Hefco V., Olariu A., Gavrilovici C., Hefco A. The role of nicotinic acetylcholine receptors in cognitive functions. Ann. Univ. Iasi. 46:2000;169-175.
11. Heisham S.J., Taylor R.C., Henningfield J.E. Nicotine and smoking: a review of effects on human performance. Exp. Clin. Psychopharmacol. 2:1994;345-395.
12. James J.R., Nordberg A. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behav. Genet. 25:1995;149-159.
13. Levin E.D., Rezvani A.H. Development of nicotinic drug therapy for cognitive disorders. Eur. J. Pharmacol. 393:2000;141-146.
14. Levin E.D., Simon B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology. 138:1998;217-230.
15. Luetje C.W., Patrick J. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11:1991;837-845.
16. Marenco T., Bernstein S., Cumming P., Clarke P.B. Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely moving rats. Br. J. Pharmacol. 129:2000;147-155.
17. Nitta A., Katono Y., Itoh A., Hasegawa T., Nabeshima T. Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system. Pharmacol. Biochem. Behav. 49:1994;807-812.
18. Picciotto M.R., Caldarone B.J., King S.L. Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropharmacology. 22:2000;451-465.
19. Pidoplichko V.I., Debiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 396:1997;401-404.
20. Riekkinen P., Sirvio J., Anitonen M., Riekkinen P. The effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning. Pharmacol. Biochem. Behav. 37:1990;405-410.
21. Spilich G.J., June L., Renner J. Cigarette smoking and cognitive performance. Br. J. Addict. 87:1992;1313-1326.
22. Van der Zee E.A., Luiten P.G.M. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory. Prog. Neurobiol. 58:1999;409-471.
23. White J.F. Synaptic regulation of mesocorticolimbic dopamine neurons. Annu. Rev. Neurosci. 19:1996;405-436.
24. Yamada K., Noda Y., Hasegawa T., Komori Y., Nikai T., Sugihara H., Nabeshima T. The role of nicotinic oxide in dizolcipine-induced impairment of spontaneous alternation behavior in mice. J. Pharmacol. Exp. Ther. 276:1996;460-466.
25. Yin R., French E.D. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study. Brain Res. Bull. 51:2000;507-514.